Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B

NCT04489537 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision (not a safety decision)

Conditions

Hemophilia A With Inhibitor
Hemophilia B With Inhibitor

Interventions

BIOLOGICAL: MarzAA

Sponsor

Catalyst Biosciences